Skip to content

    Best Agrolife

    BESTAGRO
    Chemicals·27 May 2025
    Management Summary

    Best Agrolife reported a significant turnaround in Q4 FY25, reducing its loss to ₹21.6 crores from ₹72.5 crores YoY, driven by a 103% revenue increase to ₹274 crores and a positive EBITDA of ₹4 crore. For the full year, the company improved gross margins to 29.5% and operating cash flow to ₹192 crores, while reducing inventory and borrowings. Despite challenges like market volatility and lower cotton acreage impacting patented product sales, Best Agrolife is focused on product innovation, launching new patented products like 'Shot Down,' and undertaking a ₹90 crore brownfield expansion to enhance backward integration and profitability.

    Highlights

    10
    • Q4 FY25 Revenue from operations increased by 103% YoY to ₹274 crores, compared to ₹135 crores in Q4 FY24.

    • Q4 FY25 EBITDA turned positive at ₹4 crore, a substantial improvement from negative ₹67 crore in Q4 FY24.

    • Q4 FY25 PAT loss reduced to ₹21.6 crores from negative ₹72.5 crores in Q4 FY24.

    • Full Year FY25 Gross Margin improved to 29.5% from 24.7% in FY24.

    • Full Year FY25 Inventory position reduced by ₹185 crores, a 19% YoY improvement.

    • Full Year FY25 Working Capital reduced by ₹146 crores, a 54% YoY improvement.

    • Full Year FY25 Operating Cash Flow significantly improved to ₹192 crores, a 449% increase from ₹35 crores in FY24.

    • Full Year FY25 Total Borrowing reduced by ₹161 crores, a 25% reduction from last year, with short-term borrowing decreasing from ₹670 crores to ₹453 crores.

    • Launch of new patented product 'Shot Down' and plans for 'Bestman' and 'Futagin' in FY26.

    • Brownfield expansion of technical plant with a CAPEX investment of ₹90 crores.

    Concerns

    6
    • Q4 FY25 faced challenging market conditions, including lower cotton acreage and issues with Chilli produce price.

    • Full Year FY25 Revenue from operations slightly decreased to ₹1814 crores from ₹1873 crores in FY24.

    • Full Year FY25 EBITDA contracted to ₹200 crores from ₹225 crores in FY24, attributed to increased costs for branded products strategy.

    • Patented product revenue for FY25 was ₹357 crores, lower than analyst expectations due to a 30-40% reduction in cotton acreages.

    • Forex volatility resulted in an expense of ₹10-12 crores per annum.

    • Only 25% of the committed QIP funds (₹150 crores total) have been received, with the balance 75% pending due to market challenges.

    What Changed2

    vs Q1 FY26

    Guidance items7 → 8 (+1)Risks discussed5 → 4 (-1)
    Key financials

    Metrics

    8

    Periods

    2

    Q4

    3
    • Revenue
      ₹274 Cr
      YoY+103.0%
    • EBITDA
      ₹4 Cr
    • PAT
      ₹-21.6 Cr

    FY25

    5
    • Revenue
      ₹1,814 Cr
      YoY-3.1%
    • EBITDA
      ₹200 Cr
      YoY-11.1%
    • Gross Margin
      29.5%
    • Operating Cash Flow
      ₹192 Cr
      YoY+4.5%
    • Short Term Borrowing
      ₹453 Cr
      YoY-32.4%

    Segment breakdown

    • Branded Sales₹1,190 Cr65.6%
    • Institutional Sales₹624 Cr34.4%
    Donut· Share of Revenue

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    ₹7 crores this quarter · ₹90 crores (FY26) planned

    Debt

    Debt disclosed

    Cost 9.5%

    Guidance & targets

    8
    CategoryTargetPriority
    Profitability
    EBITDA percentage
    drastic improvement
    Medium
    Profitability
    EBITDA Margin
    15-18%
    Medium
    Product Innovation
    Number of patented products launched
    three to four
    High
    Revenue
    Additional revenue from 3 new patented products (Shot Down, Bestman, Futagin)
    ₹150 crore
    Medium
    Operational Efficiency
    Sales returns
    reduction
    High
    Operational Efficiency
    Inventory position
    a lot of improvement going forward
    Medium
    Operational Efficiency
    Working capital cycle
    reduce
    High
    Capital Raising
    Balance 75% of QIP funds (₹150 crores total, 25% received)
    hopeful to raise it this year
    Low

    FY26 EBITDA Margin

    FY26 (check progress in Q1/Q2 results)
    CurrentFY25 EBITDA Margin ~11% (200cr EBITDA on 1814cr revenue)
    Target15-18%

    Why it matters

    Management has guided for a significant improvement in profitability, crucial for the investment thesis.

    Yes, in that range of 15% to 18%.

    How to verify

    key_financials.metrics[label='EBITDA Margin']

    Risks & concerns

    4
    RiskSeverity

    Challenging market conditions

    Market conditions were more challenging than anticipated, particularly in cotton acreage and Chilli produce price.Management acknowledged

    medium

    Sales returns

    Sales return has always been a challenge, a major concern in the agrochemical industry, but new policies are in place for FY26.Management acknowledged

    medium

    Forex volatility

    Forex volatility between November and February resulted in ₹10-12 crores per annum in expenses.Management acknowledged

    low

    Delay in QIP fund realization

    Balance 75% of QIP funds (₹112.5 crores) are pending due to market challenges, with management hopeful to raise it this year.Analyst acknowledged

    medium

    Q&A highlights

    8

    “this will take at least a couple of years before we see the revenue stream from product like Ronfen in Africa.”

    Clarifies that international patent wins have a long lead time for revenue, managing investor expectations.

    asked by Hemant

    3 min read7 chapters

    Detailed Narrative

    01

    Q4 FY25 Performance & Turnaround

    Best Agrolife demonstrated a significant turnaround in Q4 FY25, with revenue from operations surging by 103% year-on-year to ₹274 crores, compared to ₹135 crores in Q4 FY24. The company achieved a positive EBITDA of ₹4 crore, a substantial improvement from a negative EBITDA of ₹67 crore in the prior year. Consequently, the net loss for the quarter was reduced to ₹21.6 crores from ₹72.5 crores in Q4 FY24, reflecting enhanced operational efficiency and cost optimization efforts.

    02

    Full Year FY25 Financial Highlights

    For the full fiscal year 2025, Best Agrolife improved its gross margin from 24.7% to 29.5%, indicating a focus on sustainable growth and inventory management. Operating cash flow saw a drastic improvement, reaching ₹192 crores, a 449% increase from ₹35 crores in FY24. The company also successfully reduced its inventory by ₹185 crores (19% YoY) and working capital by ₹146 crores (54% YoY), leading to a 25% reduction in total borrowings by ₹161 crores, with short-term borrowings decreasing from ₹670 crores to ₹453 crores.

    03

    Product Innovation & Pipeline

    Best Agrolife continues its focus on product innovation, aiming to release three to four patented products annually. The company officially launched 'Shot Down,' a powerful herbicide, and plans to launch two more patented insecticides, 'Bestman' and 'Futagin,' in FY26. These products are designed to be farmer-oriented, address multiple problems with single solutions, and support sustainable farming practices, with the three new products expected to generate approximately ₹150 crore in additional revenue in their first year.

    04

    Operational Efficiency & Cost Optimization

    The company has implemented strategic sales policies for FY26 to drive demand for specialty products and reduce sales returns, which were 17-18% in FY25. Cost optimization efforts include restructuring and merging regions to reduce OPEX, and changes in policies to reduce sales returns and improve inventory management. These initiatives are expected to significantly improve profitability and accountability across sales channels, with a focus on the bottom line rather than just top-line growth for FY26.

    05

    Backward Integration & CAPEX Plans

    Best Agrolife is undertaking a brownfield expansion of its technical plant in Gajraula, Uttar Pradesh, with a CAPEX investment of ₹90 crores. This expansion, which will take 10-12 months to complete, aims to create three functionally separate blocks for the production of insecticides, fungicides, and herbicides. The company has already spent ₹7-10 crores on this project and expects effective revenue and profit generation to begin from FY27, enhancing backward integration and reducing dependence on external raw material sources.

    06

    International Expansion & Partnerships

    The company is making progress in international expansion, with exports to Africa showing early traction and interest from countries like Sri Lanka, Vietnam, Thailand, and Bolivia in its patented products. An international patent for Ronfen in Africa has been granted. Collaborations, such as the MOU with Shanghai E-Tong Chemical Company, are aimed at exploring joint registration opportunities and technical know-how, with early work on intermediate collaboration already in progress.

    07

    Challenges & Outlook for FY26

    Despite a challenging Q4 FY25 marked by lower cotton acreage and chilli price issues, management remains optimistic for FY26, anticipating good Q1 and Q2 numbers due to favorable seasonal conditions. The company's focus for the upcoming year is on profitability, improving gross margins, and reducing costs, with a target EBITDA margin in the range of 15-18%. However, the full realization of the balance 75% of QIP funds (₹112.5 crores) is pending due to current market challenges🌐, which the company hopes to address as market conditions improve.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.